The development of dilated cardiomyopathy from chronic myocarditis is
caused by the persistence of enteroviral infections and chronic myocar
dial inflammation. New molecularbiological and immunohistochemical tec
hniques improve diagnosis and allow predictions of the development of
the disease. This facilitates the decision for a specific immunomodula
tory therapy.